The science and practice of lithium therapy

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 3, 2012, Pages 192-211

  Malhi, Gin S ^a,b   Tanious, Michelle ^a,b   Das, Pritha ^a,b   Berk, Michael ^c,d,e,f,g,h  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g BARWON HEALTH   (Australia)

^h FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Bipolar disorder; lithium; mood stabilizer; neuroprotection; suicide

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CREATININE; DOPAMINE; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3; INOSITOL; LITHIUM; LITHIUM CARBONATE; N ACETYLASPARTIC ACID; PROTEIN BCL 2; LITHIUM DERIVATIVE; TRANQUILIZER;

AGE DISTRIBUTION; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL PRACTICE; DIARRHEA; DRUG BLOOD LEVEL; DRUG INDUCED HEADACHE; DRUG RELEASE; DRUG TOLERABILITY; FATIGUE; HUMAN; KIDNEY FUNCTION; LACTATION; LONG TERM CARE; MAINTENANCE THERAPY; MONOTHERAPY; NAUSEA; NEUROPROTECTION; OBESITY; PATIENT COMPLIANCE; POLYURIA; PRACTICE GUIDELINE; PREGNANCY; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; THIRST; TREATMENT OUTCOME; TREMOR; VOMITING; WEIGHT GAIN; BIOLOGICAL MODEL; DRUG ADMINISTRATION; DRUG EFFECT; PSYCHOLOGICAL ASPECT; SYNAPTIC TRANSMISSION;

ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG ADMINISTRATION SCHEDULE; HUMANS; LITHIUM COMPOUNDS; MEDICATION ADHERENCE; MODELS, BIOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 84863831234     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412437346     Document Type: Review

References (186)

1. Agam G, Bersudsky Y, Berry GT, et al. Knockout mice in understanding the mechanism of action of lithium. Biochemical Society Transactions. 2009 ; 37: 1121-1125
2. Alda M, Hajek T, Calkin C, et al. Treatment of bipolar disorder: new perspectives. Annals of Medicine. 2009 ; 41: 186-196
3. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis [see comment]. The American Journal of Psychiatry. 1999 ; 156: 1686-1696 (Pubitemid 29517559)
4. Altamura AC, Gomeni R, Sacchetti E, et al. Plasma and intracellular kinetics of lithium after oral administration of various lithium salts. European Journal of Clinical Pharmacology. 1977 ; 12: 59-63 (Pubitemid 8158560)
5. Practice guideline for the treatment of patients with bipolar disorder (revision). The American Journal of Psychiatry. 2002 ; 159: 1-50
6. Baldessarini RJ, Tondo L. Does lithium treatment still work? Evidence of stable responses over three decades. Archives of General Psychiatry. 2000 ; 57: 187-190 (Pubitemid 30075271)
7. Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review [see comment] [erratum appears in Bipolar Disord 2007; 9: 314]. Bipolar Disorders. 2006 ; 8: 625-639 (Pubitemid 44567144)
8. Batlle DC, von Riotte AB, Gaviria M, et al. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. New England Journal of Medicine. 1985 ; 312: 408-414 (Pubitemid 15130142)
9. Bauer M, Goetz T, Glenn T, et al. The thyroid-brain interaction in thyroid disorders and mood disorders. Journal of Neuroendocrinology. 2008 ; 20: 1101-1114
10. Bendz H. Kidney function in lithium-treated patients. Acta Psychiatrica Scandinavica. 1983 ; 68: 303-324
11. Bendz H, Aurell M. Drug-induced diabetes insipidus: incidence, prevention and management. Drug Safety. 1999 ; 21: 449-456 (Pubitemid 30021101)
12. Berk L, Hallam KT, Colom F, et al. Enhancing medication adherence in patients with bipolar disorder. Human Psychopharmacology: Clinical and Experimental. 2010a ; 25: 1-16
13. Berk L, Jorm AF, Kelly CM, et al. Development of guidelines for caregivers of people with bipolar disorder: a Delphi expert consensus study. Bipolar Disorders. 2011a ; 13: 556-570
14. Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. International Journal of Neuropsychopharmacology. 2009 ; 12: 441-445
15. Berk M, Malhi GS. Should antipsychotics take pole position in mania treatment?. The Lancet. 2011 ; 378: 1279-1281
16. Berk M, Berk L, Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disorders. 2004 ; 6: 504-518 (Pubitemid 39562418)
17. Berk M, Conus P, Kapczinski F, et al. From neuroprogression to neuroprotection: implications for clinical care. The Medical Journal of Australia. 2010b ; 193: S36 - S40
18. Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews. 2011b ; 35: 804-817
19. Bhagwagar Z, Goodwin GM. The role of lithium in the treatment of bipolar depression. Clinical Neuroscience Research. 2002 ; 2: 222-227 (Pubitemid 35375335)
20. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. American Journal of Kidney Diseases. 1987 ; 10: 329-345 (Pubitemid 17161686)
21. Bowden CL. The ability of lithium and other mood stabilisers to decrease suicide risk and prevent relapse. Current Psychiatric Reports. 2000 ; 2: 490-494
22. Bowden CL, Mosolov S, Hranov L, et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. International Clinical Psychopharmacology. 2010 ; 25: 60-67
23. Bowen RC, Grof P, Grof E. Less frequent lithium administration and lower urine volume. The American Journal of Psychiatry. 1991 ; 148: 189-192
24. Brunello N, Tascedda F. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. International Journal of Neuropsychopharmacology. 2003 ; 6: 181-189 (Pubitemid 36850970)
25. Cade JFJ. Lithium salts in the treatment of psychotic excitement. The Medical Journal of Australia. 1949 ; 2: 349-352
26. Carroll JA, Jefferson JW, Greist JH. Treating tremor induced by lithium. Hospital and Community Psychiatry. 1987 ; 38: 1280
27. Carson S, Roberts S Clinical Pharmacokinetics. 2001 ) Lithium. In: MurphyJ (ed) Clinical Pharmacokinetics. 2nd edition.Bethesda, MD: American Society of Health System Pharmacists, pp.229-245. Murphy J, ed. Bethesda, MD: American Society of Health System Pharmacists ; 2001: 229-245.
28. Cavanagh J, Smyth R, Goodwin GM. Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatrica Scandinavica. 2004 ; 109: 91-95 (Pubitemid 38186819)
29. Chakrabarti S. Thyroid functions and bipolar affective disorder. Journal of Thyroid Research. 2011 2011 ;: 13
30. Chang YC, Lin HN, Deng HC. Subclinical lithium neurotoxicity: correlation of neural conduction abnormalities and serum lithium level in manic-depressive patients with lithium treatment. Acta Neurologica Scandinavica. 1990 ; 82: 82-86
31. Chen C, Lennox B, Jacob R, et al. Explicit and implicit facial affect recognition in manic and depressed states of bipolar disorder: a functional magnetic resonance imaging study. Biological Psychiatry. 2006 ; 59: 31-39 (Pubitemid 43005233)
32. Chen KP, Shen WW, Lu ML, et al. Implication of serum concentration monitoring in patients with lithium intoxication. Psychiatry and Clinical Neurosciences. 2004 ; 58: 25-29 (Pubitemid 38200367)
33. Chen ST, Altshuler LL, Melnyk KA, et al. Efficacy of lithium vs. valproate in the treatment of mania in the elderly: a retrospective study. Journal of Clinical Psychiatry. 1999 ; 60: 181-186 (Pubitemid 29168691)
34. Chiu C-T, Chuang D-M. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacology and Therapeutics. 2010 ; 128: 281-304
35. Cipriani A, Burgess S, Carney S, et al. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder (Review). Cochrane Database of Systematic Reviews. 2006 ; 4: CD003492
36. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials [see comment]. The American Journal of Psychiatry. 2005 ; 162: 1805-1819 (Pubitemid 41428610)
37. Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium [see comment] [erratum appears in JAMA 1994; 271: 1485]. The Journal of the American Medical Association. 1994 ; 271: 146-150
38. Colom F, Vieta E, Martinez-Aran A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry. 2003 ; 60: 402-407 (Pubitemid 36403001)
39. Coppen A, Abou-Saleh M, Millin P, et al. Decreasing lithium dosage reduces morbitidy and side-effects during prophylaxis. Journal of Affective Disorders. 1983 ; 5: 353-362 (Pubitemid 14244156)
40. Coresh J, Astor B, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. American Journal of Kidney Diseases. 2003 ; 41: 1-12 (Pubitemid 36043346)
41. Coryell W. Rapid cycling bipolar disorder: clinical characteristics and treatment options. CNS Drugs. 2005 ; 19: 557-569 (Pubitemid 41058369)
42. Coryell W. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disorders. 2009 ; 11: 77-83
43. Deranieh RM, Greenberg ML. Cellular consequences of inositol depletion. Biochemical Society Transactions. 2009 ; 37: 1099-1103
44. Dixon JF, Hokin LE. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95: 8363-8368 (Pubitemid 28326118)
45. Eastham JH, Jeste DV, Young R. Assessment and treatment of bipolar disorder in the elderly. Drugs & Aging. 1998 ; 12: 205-224 (Pubitemid 28130096)
46. Efrati S, Averbukh M, Berman S, et al. N-Acetylcysteine ameliorates lithium-induced renal failure in rats. Nephrology Dialysis Transplantation. 2005 ; 20: 65-70 (Pubitemid 40207609)
47. Even C, Richard H, Thuile J, et al. Characteristics of voluntary participants versus nonparticipants in a psychoeducation program for euthymic patients with bipolar disorder. Journal of Nervous and Mental Disease. 2007 ; 195: 262-265 (Pubitemid 46673549)
48. Eyer F, Pfab R, Felgenhauer N, et al. Lithium poisoning: pharmacokinetics and clearance during different therapeutic measures. Journal of Clinical Psychopharmacology. 2006 ; 26: 325-330 (Pubitemid 43804627)
49. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. International Clinical Psychopharmacology. 2001 ; 16: 153-162 (Pubitemid 32402360)
50. Ferrie L, Young AH, McQuade R. Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat. Journal of Psychopharmacology. 2005 ; 19: 229-234 (Pubitemid 40694940)
51. Ferrie L, Young AH, McQuade R. Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat. International Journal of Neuropsychopharmacology. 2006 ; 9: 729-735 (Pubitemid 46122772)
52. Finley PR, O'Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. Journal of Clinical Psychopharmacology. 1996 ; 16: 68-71 (Pubitemid 26059168)
53. Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clinical Pharmacokinetics. 1995 ; 29: 172-191
54. Fliser D, Franek E, Joest M, et al. Renal function in the elderly: impact of hypertension and cardiac function. Kidney International. 1997 ; 51: 1196-1204 (Pubitemid 27186546)
55. Fountoulakis KN. An update of evidence-based treatment of bipolar depression: where do we stand?. Current Opinion in Psychiatry. 2010 ; 23: 19-24
56. Fountoulakis KN, Grunze H, Panagiotidis P, et al. Treatment of bipolar depression: an update. Journal of Affective Disorders. 2008a ; 109: 21-34 (Pubitemid 351707705)
57. Fountoulakis KN, Vieta E, Bouras C, et al. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?. International Journal of Neuropsychopharmacology. 2008b ; 11: 269-287 (Pubitemid 351231818)
58. Freeman MP, Freeman SA. Lithium: clinical considerations in internal medicine. American Journal of Medicine. 2006 ; 119: 478-481 (Pubitemid 43795184)
59. Frye MA, Ketter TA, Altshuler LL, et al. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. Journal of Affective Disorders. 1998 ; 48: 91-104 (Pubitemid 28244210)
60. Fyro B, Pettersson U, Sedvall G. Serum lithium levels and side effects during administration of lithium carbonate and two slow release lithium preparations to human volunteers. Pharmacologia Clinica. 1970 ; 2: 236-240
61. Gash AJ, Chhabra S, Eccleston D. Lithium augmentation in a case of renal impairment: risk vs. benefit. Journal of Affective Disorders. 1995 ; 34: 51-53
62. Geddes JR, Burgess S, Hawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. The American Journal of Psychiatry. 2004 ; 161: 217-222 (Pubitemid 38419270)
63. Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. The Lancet. 2010 ; 375: 385-395
64. Gershon S, Chengappa KR, Malhi GS. Lithium specificity in bipolar illness: a classic agent for a classic disorder. Bipolar Disorders. 2009 ; 11: 34-44
65. Gitlin M. Lithium and the kidney - an updated review. Drug Safety. 1999 ; 20: 231-243
66. Goldberg JF, Berk M Bipolar Disorder. Yatham LN Maj M, ed. Chichester: John Wiley & Sons, Ltd ; 2010: 333-341.
67. Goodwin FK, Fireman B, Simon GE, et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. The Journal of the American Medical Association. 2003 ; 290: 1467-1473 (Pubitemid 37430401)
68. Goodwin GM, Malhi GS. What is a mood stabilizer?. Psychological Medicine. 2007 ; 37: 609-614 (Pubitemid 46511086)
69. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: Part II: clinical pharmacology and therapeutic monitoring. CNS Drugs. 2009a ; 23: 331-349
70. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: Part III: clinical safety. CNS Drugs. 2009b ; 23: 397-418
71. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: Part I: clinical efficacy in bipolar disorder. CNS Drugs. 2009c ; 23: 225-240
72. Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. The World Journal of Biological Psychiatry. 2009 ; 10: 85-116
73. Hallahan B, Newell J, Soares JC, et al. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biological Psychiatry. 2011 ; 69: 326-335
74. Hokin LE, Dixon JF, Los GV. A novel action of lithium: stimulation of glutamate release and inositol 1,4,5 trisphosphate accumulation via activation of the N-methyl d-aspartate receptor in monkey and mouse cerebral cortex slices. Advances in Enzyme Regulation. 1996 ; 36: 229-244 (Pubitemid 27065713)
75. Hopkins HS, Gelenberg AJ. Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disorders. 2000 ; 2: 174-179
76. Hsu CH, Liu PY, Chen JH, et al. Electrocardiographic abnormalities as predictors for over-range lithium levels. Cardiology. 2005 ; 103: 101-106
77. Hunter R. Steady-state pharmacokinetics of lithium carbonate in healthy subjects. British Journal of Clinical Pharmacology. 1988 ; 25: 375-380
78. Ikonomov OC, Manji HK. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. The American Journal of Psychiatry. 1999 ; 156: 1506-1514 (Pubitemid 29459980)
79. Jensen HV, Olafsson K, Bille A, et al. Lithium every second day. A new treatment regimen?. Lithium. 1990 ; 1: 55-58 (Pubitemid 20375421)
80. Johnson GF, Hunt GE. Pharmacokinetics of lithium preparations in patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 1984 ; 8: 63-70 (Pubitemid 14126057)
81. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors [see comment]. The British Journal of Psychiatry. 1999 ; 175: 336-339 (Pubitemid 29470863)
82. Karniol IG, Dalton J, Lader MH. Acute and chronic effects of lithium chloride on physiological and psychological measures in normals. Psychopharmacology. 1978 ; 57: 289-294 (Pubitemid 8357032)
83. Kato T, Fujii K, Shioiri T, et al. Lithium side effects in relation to brain lithium concentration measured by lithium-7 magnetic resonance spectroscopy. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 1996 ; 20: 87-97 (Pubitemid 26128164)
84. Keck PE, McElroy SL, Keck PE, et al. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. Journal of Clinical Psychiatry. 2003 ; 64: 1426-1435 (Pubitemid 41270100)
85. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia?. Bipolar Disorders. 2010 ; 12: 87-94
86. Kessing LV, Sondergard L, Kvist K, et al. Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. Bipolar Disorders. 2007 ; 9: 730-736 (Pubitemid 350042408)
87. Klein E, Lavie P, Meiraz R, et al. Increased motor activity and recurrent manic episodes: predictors of rapid relapse in remitted bipolar disorder patients after lithium discontinuation. Biological Psychiatry. 1992 ; 31: 279-284
88. Kleindienst N, Greil W. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?. Journal of Clinical Psychiatry. 2004 ; 65: 966-974
89. Kleindienst N, Severus WE, Greil W. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multi-center trial. International Clinical Psychopharmacology. 2007 ; 22: 125-131 (Pubitemid 46562465)
90. Kleindienst N, Severus WE, Moller HJ, et al. Is polarity of recurrence related to serum lithium level in patients with bipolar disease?. European Archives of Psychiatry and Clinical Neuroscience. 2005 ; 255: 72-74 (Pubitemid 40558109)
91. Kropf D, Muller-Oerlinghausen B. Changes in learning, memory, and mood during lithium treatment. Approach to a research strategy. Acta Psychiatrica Scandinavica. 1979 ; 59: 97-124 (Pubitemid 9085144)
92. Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function. Journal of Psychiatry & Neuroscience. 1999 ; 24: 227-233 (Pubitemid 29289389)
93. Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid. 1998 ; 8: 909-913 (Pubitemid 28514183)
94. Lenox RH, McNamara RK, Papke RL, et al. Neurobiology of lithium: an update. Journal of Clinical Psychiatry. 1998 ; 59: 37-47 (Pubitemid 28313241)
95. Lepkifker E, Iancu I, Horesh N, et al. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation. Depression and Anxiety. 2007 ; 24: 571-576 (Pubitemid 350274858)
96. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. Journal of the American Geriatrics Society. 1985 ; 33: 278-285 (Pubitemid 15087125)
97. Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. Journal of Psychopharmacology. 2006 ; 20: 347-355
98. Ljubicic D, Letica-Crepulja M, Vitezic D, et al. Lithium treatments: single and multiple daily dosing. Canadian Journal of Psychiatry. 2008 ; 53: 323-331 (Pubitemid 351838512)
99. Llewellyn A, Stowe ZN, Strader JR. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. Journal of Clinical Psychiatry. 1998 ; 59: 57-64
100. Lombardi G, Panza N, Biondi B, et al. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study. Journal of Endocrinological Investigation. 1993 ; 16: 259-263 (Pubitemid 23185918)
101. Lydiard RB, Gelenberg AJ. Hazards and adverse effects of lithium. Annual Review of Medicine. 1982 ; 33: 327-344
102. Machado-Vieira R, Manji HK, Zarate CA. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disorders. 2009a ; 11: 92-109
103. Machado-Vieira R, Manji HK, Zarate CA, et al. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disorders. 2009b ; 11: 92-109
104. McKnightRFAdidaMBudgeK. (2012) Lithium toxicity profile: a systematic review and meta-analysis. The Lancet (in press).
105. Mak TW, Shek CC, Chow CC, et al. Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. Journal of Clinical Endocrinology and Metabolism. 1998 ; 83: 3857-3859 (Pubitemid 28513562)
106. Malhi GS. The king is dead, long live the king! The restoration of BALANCE. Bipolar Disorders. 2010 ; 12: 681-684
107. MalhiGSBerkM (2012) Is the safety of lithium no longer in the balance?The Lancet (in press).
108. Malhi GS, Gershon S. Ion men and their mettle. Australian and New Zealand Journal of Psychiatry. 2009 ; 43: 1091-1095
109. Malhi GS, Tanious M. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations. CNS Drugs. 2011 ; 25: 289-298
110. Malhi GS, Adams D, Berk M. Is lithium in a class of its own? A brief profile of its clinical use. Australian and New Zealand Journal of Psychiatry. 2009a ; 43: 1093-1104
111. Malhi GS, Adams DA, Berk M. Medicating mood with maintenance in mind: bipolar depression pharmacotherapy. Bipolar Disorders. 2009b ; 11: 55-76
112. Malhi GS, Adams D, Cahill CM, et al. The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice. Drugs. 2009c ; 69: 2063-2101
113. Malhi GS, Adams DA, Lampe L, et al. Clinical practice recommendations for bipolar disorder. Acta Psychiatrica Scandinavica. 2009d ; 119: 27-46
114. Malhi GS, Adams DA, Porter R, et al. Clinical practice recommendations for depression. Acta Psychiatrica Scandinavica. 2009e ; 119: 8-26
115. MalhiGSBarghDMcIntyreR. (2012) The clinical management of bipolar disorder complexity using a stratified model. Bipolar Disorders (in press).
116. Malhi GS, Chengappa KNR, Gershon S, et al. Hypomania: hype or mania?. Bipolar Disorders. 2010 ; 12: 758-763
117. Malhi GS, Chengappa KNR, Gershon S, et al. Atypical mood stabilizers: a new role for neuroleptics?. Bipolar Disorders. 2011a ; 13: 583-586
118. Malhi GS, Mitchell PB, Salim S. Bipolar depression: management options. CNS Drugs. 2003 ; 17: 9-25 (Pubitemid 36044346)
119. Malhi GS, Tanious M, Gershon S. The lithiumeter: a measured approach. Bipolar Disorders. 2011b ; 13: 219-226
120. Mamiya K, Sadanaga T, Sekita A, et al. Lithium concentration correlates with QTc in patients with psychosis. Journal of Electrocardiology. 2005 ; 38: 148-151 (Pubitemid 40616140)
121. Mander AJ, Loudon JB. Rapid recurrence of mania following abrupt discontinuation of lithium. The Lancet. 1988 ; 332: 15-17
122. Manji HK, Lenox RH. Signaling: cellular insights into the pathophysiology of bipolar disorder. Biological Psychiatry. 2000 ; 48: 518-530
123. Markowitz GS, Radhakrishnan JAI, Kambham N, et al. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. Journal of the American Society of Nephrology. 2000 ; 11: 1439-1448 (Pubitemid 30483460)
124. Marmol F. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2008 ; 32: 1761-1771
125. Mester R, Toren P, Mizrachi I, et al. Caffeine withdrawal increases lithium blood levels. Biological Psychiatry. 1995 ; 37: 348-350
126. Morriss R, Benjamin B, Morriss R, et al. Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease. The British Journal of Psychiatry. 2008 ; 193: 93-95
127. Muller-Oerlinghausen B. Arguments for the specificity of the antisuicidal effect of lithium. European Archives of Psychiatry and Clinical Neuroscience. 2001 ; 251: II/72 - II/75
128. Muzina DJ. Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium. Bipolar Disorders. 2009 ; 11: 84-91
129. Ng F, Oommen KM, Wilting I, et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disorders. 2009 ; 11: 559-595
130. London: National Institute for Health and Clincial Excellence ; 2006
131. Nivoli AMA, Colom F, Murru A, et al. New treatment guidelines for acute bipolar depression: a systematic review. Journal of Affective Disorders. 2011 ; 129: 14-26
132. Nonaka S, Hough CJ, Chuang D-M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95: 2642-2647 (Pubitemid 28145996)
133. Oakley PW, Whyte IM, Carter GL. Lithium toxicity: an iatrogenic problem in susceptible individuals. Australian and New Zealand Journal of Psychiatry. 2001 ; 35: 833-840 (Pubitemid 34048456)
134. O'Brien TW, Klein PS. Validating GSK3 as an in vivo target of lithium action. Biochemical Society Transactions. 2009 ; 37: 1133-1138
135. Okusa MD, Crystal LJT. Clinical manifestations and management of acute lithium intoxication. The American Journal of Medicine. 1994 ; 97: 383-389 (Pubitemid 24313101)
136. Pachoreck R Clinical Pharmacokinetics. 2001 ) Estimating creatinine clearance. In: MurphyJ (ed) Clinical Pharmacokinetics. 2nd edition.Bethesda, MD: American Society of Health System Pharmacists, pp.1-10. Murphy J, ed. Bethesda, MD: American Society of Health System Pharmacists ; 2001: 1-10.
137. Perlis R, Sachs G, Lafer B, et al. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. The American Journal of Psychiatry. 2002 ; 159: 1155-1159 (Pubitemid 34743255)
138. Perry PJ, Dunner FJ, Hahn RL, et al. Lithium kinetics in single daily dosing. Acta Psychiatrica Scandinavica. 1981 ; 64: 281-294 (Pubitemid 12242337)
139. Phelan KM, Mosholder AD, Lu S, et al. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. Journal of Clinical Psychiatry. 2003 ; 64: 1328-1334 (Pubitemid 37490238)
140. Plenge P, Amin M, Agarwal AK, et al. Prophylactic efficacy of lithium administered every second day: a WHO multicentre study. Bipolar Disorders. 1999 ; 1: 109-116
141. Plenge P, Stensgaard A, Jensen HV, et al. 24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy. Biological Psychiatry. 1994 ; 36: 511-516
142. Post RM, Jimerson DC, Bunney WE, et al. Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology. 1980 ; 67: 297-305 (Pubitemid 10117612)
143. Post RM, Speer AM, Hough CJ, et al. Neurobiology of bipolar illness: implications for future study and therapeutics. Annals of Clinical Psychiatry. 2003 ; 15: 85-94 (Pubitemid 38101800)
144. Roose SP, Nurnberger JI, Dunner DL, et al. Cardiac sinus node dysfunction during lithium treatment. The American Journal of Psychiatry. 1979 ; 136: 804-806 (Pubitemid 9214999)
145. Rosa AR, Marco M, Fachel JM, et al. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2007 ; 31: 217-224 (Pubitemid 44959264)
146. Rosenqvist M, Bergfeldt L, Aili H, et al. Sinus node dysfunction during long term lithium treatment. British Heart Journal. 1993 ; 70: 371-375 (Pubitemid 23309549)
147. Rybakowski JK, Suwalska A. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. The International Journal of Neuropsychopharmacology. 2010 ; 13: 617-622
148. Rybakowski JK, Permoda-Osip A, Borkowska A. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. European Neuropsychopharmacology. 2009 ; 19: 791-795
149. Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neuroscience and Biobehavioral Reviews. 2009 ; 33: 699-771
150. Schou M, Vestergaard P. Prospective studies on a lithium cohort. 2. Renal function. Water and electrolyte metabolism. Acta Psychiatrica Scandinavica. 1988 ; 78: 427-433
151. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. Journal of Clinical Psychiatry. 2002 ; 63: 384-390 (Pubitemid 34507214)
152. Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clinical Neuropharmacology. 1998 ; 21: 176-180 (Pubitemid 28248777)
153. Severus WE, Kleindienst N, Evoniuk G, et al. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study. Journal of Affective Disorders. 2009 ; 115: 466-470
154. Severus WE, Kleindienst N, Seemuller F, et al. What is the optimal serum lithium level in the long-term treatment of bipolar disorder - a review?. Bipolar Disorders. 2008 ; 10: 231-237 (Pubitemid 351637686)
155. Shafti SS. Olanzapine vs. lithium in management of acute mania. Journal of Affective Disorders. 2010 ; 122: 273-276
156. Shelley RK, Silverstone T. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects. International Clinical Psychopharmacology. 1986 ; 1: 324-331
157. Shulman KI. Lithium for older adults with bipolar disorder: should it still be considered a first-line agent?. Drugs & Aging. 2010 ; 27: 607-615
158. Silverstone PH, McGrath BM, Kim H, et al. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disorders. 2005 ; 7: 1-10 (Pubitemid 40227831)
159. Silverstone T. Is lithium still the maintenance treatment of choice for bipolar disorder?. CNS Drugs. 2000 ; 14: 81-94
160. Soares JC, Boada F, Spencer S, et al. Brain lithium concentrations in bipolar disorder patients: preliminary (7) Li magnetic resonance studies at 3 T. Biological Psychiatry. 2001 ; 49: 437-443 (Pubitemid 32234306)
161. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs & Aging. 2000 ; 16: 165-177 (Pubitemid 30166918)
162. Squire LR, Judd LL, Janowsky DS, et al. Effects of lithium carbonate on memory and other cognitive functions. The American Journal of Psychiatry. 1980 ; 137: 1042-1046 (Pubitemid 10048879)
163. Steckler TL. Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital. Journal of Clinical Psychopharmacology. 1994 ; 14: 336-339 (Pubitemid 24316931)
164. Suppes T, Marangell LB, Bernstein IH, et al. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. Journal of Affective Disorders. 2008 ; 111: 334-343
165. Tajes M, Yeste-Velasco M, Zhu X, et al. Activation of Akt by lithium: pro-survival pathways in aging. Mechanisms of Ageing and Development. 2009 ; 130: 253-261
166. Thomsen K, Leyssac PP. Acute effects of various diuretics on lithium clearance. Studies in rats on medium and low sodium diet. Renal Physiology. 1986 ; 9: 1-8 (Pubitemid 16153688)
167. Timmer RT, Sands JM. Lithium intoxication. Journal of the American Society of Nephrology. 1999 ; 10: 666-674 (Pubitemid 29117649)
168. Tohen M, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry. 2002 ; 59: 62-69 (Pubitemid 34044408)
169. Van Erp TGM, Thompson PM, Kieseppä T, et al. Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins. Human Brain Mapping. 2011 2011
170. Van Lieshout RJ, MacQueen GM. Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review. The British Journal of Psychiatry. 2010 ; 196: 266-273
171. Vestergaard P, Poulstrup I, Schou M. Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatrica Scandinavica. 1988 ; 78: 434-441
172. Vieta E, Locklear J, Gunther O, et al. Treatment options for bipolar depression: a systematic review of randomized, controlled trials. Journal of Clinical Pyschopharmacology. 2010 ; 30: 579-590
173. Viguera AC, Cohen LS. The course and management of bipolar disorder during pregnancy. Psychopharmacology Bulletin. 1998 ; 34: 339-346 (Pubitemid 28537957)
174. Viguera AC, Newport DJ, Ritchie J, et al. Lithium in breast milk and nursing infants: clinical implications. The American Journal of Psychiatry. 2007 ; 164: 342-345
175. Vincent A, Baruch P, Vincent P. Early onset of lithium-associated hypothyroidism. Journal of Psychiatry & Neuroscience. 1993 ; 18: 74-77
176. Widerlov E. A comparative double-blind study of the side effects of Litarex and Lithionit Durettes. Acta Psychiatrica Scandinavica. 1976 ; 54: 294-302
177. Wijeratne C, Draper B. A reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity. Australian and New Zealand Journal of Psychiatry. 2011 ; 45: 1026-1032
178. Wilkinson D, Holmes C, Woolford J, et al. Prophylactic therapy with lithium in elderly patients with unipolar major depression [see comment]. International Journal of Geriatric Psychiatry. 2002 ; 17: 619-622 (Pubitemid 34784716)
179. Wilting I, de Vries F, Thio BM, et al. Lithium use and the risk of fractures. Bone. 2007 ; 40: 1252-1258 (Pubitemid 46550974)
180. Wingo AP, Wingo TS, Harvey PD, et al. Effects of lithium on cognitive performance: a meta-analysis. Journal of Clinical Psychiatry. 2009 ; 70: 1588-1597
181. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders. 2005 ; 7: 5-69 (Pubitemid 41065248)
182. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disorders. 2006 ; 8: 721-739 (Pubitemid 44824712)
183. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders. 2009 ; 11: 225-255
184. Yildiz A, Vieta E, Leucht S, et al. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology. 2011 ; 36: 375-389
185. Yoshida K, Smith B, Kumar R. Psychotropic drugs in mothers' milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding. Journal of Psychopharmacology. 1999 ; 13: 64-80 (Pubitemid 29141277)
186. Young AH, Hammond JM. Lithium in mood disorders: increasing evidence base, declining use?. The British Journal of Psychiatry. 2007 ; 191: 474-476 (Pubitemid 350273206)